Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [111In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer

Chan, Conrad; Prozzo, Vanessa; Aghevlian, Sadaf; Reilly, Raymond M.

doi:10.1186/s41181-022-00186-9

EJNMMI Radiopharmacy and Chemistry

Article metrics
Last updated: Wed, 15 May 2024 8:49:22 Z

Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [¹¹¹In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer

Access & Citations

2354

Article Accesses
0

Web of Science
2

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.